產(chǎn)品展示
- CYT-201Recombinant Human EPO 重組人促紅細(xì)胞生成素5ug/50ugPeprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:2064
- CYT-201Recombinant Human EPO 重組人促紅細(xì)胞生成素5ug/50ugPeprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:1697
- CYT-201Recombinant Human EPO 重組人促紅細(xì)胞生成素5ug/50ugPeprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:1954
- 450-32Recombinant Murine VEGF 重組小鼠血管內(nèi)皮生長(zhǎng)因子2ug/10ug/Peprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:1874
- 450-32Recombinant Murine VEGF 重組小鼠血管內(nèi)皮生長(zhǎng)因子2ug/10ug/Peprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:1689
- 450-32Recombinant Murine VEGF 重組小鼠血管內(nèi)皮生長(zhǎng)因子2ug/10ug/Peprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:1754
- 100-20Recombinant Human VEGF165 重組人血管內(nèi)皮生長(zhǎng)因子16510ug/1mg/Peprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:1870
- 100-20Recombinant Human VEGF165 重組人血管內(nèi)皮生長(zhǎng)因子16510ug/1mg/Peprotech時(shí)間:2025-09-29型號(hào):廠商性質(zhì):代理商瀏覽量:2270


